宝山区甲肝疫苗免疫接种成本-效益分析

[目的 ]　分析研究宝山区推行接种甲肝疫苗预防控制甲型肝炎的经济效益。 [方法 ]　参考WHO推荐的“国民收入法”评价指标。 [结果 ]　 1994～ 1998年宝山区实施接种甲肝疫苗后 ,病毒性甲型肝炎发病率明显下降 ,测算预期减少甲型肝炎病例 35 81例。计算此阶段取得的经济效益为 34 0 5 .85万元 ,扣除成本后的净效益为2 5 47.45万元。成本效益比为 1:3.97。 [结论 ]　应用WHO“国民收入法”评价指标可较好地对甲肝疫苗预防接种进行成本 -效益分析 ,结果证明其经济效益显著。

A cost benefit analysis of hepatitis A virus vaccine immunization in Baoshan

objectives] To analyze the economic benefit of prevention and control of hepatitis A by vaccinate HAV vaccine in Bao shan. [Method] Refer to the evaluation index of national-income-method which WHO recommended. [Results] The incidence of hepatitis A reduced significantly through vaccinate HAV vaccine in 1994～1998 and 3581 cases of hepatitis had been reduced expectantly. The gross economic benefit of this period was $34058500 by calculation and the net benefit was $25474500. The cost-benefit-ratio was 1:3.97. [Conclusions] The cost-benefit of HAV vaccine immunization could be better analyzed with WHO evaluation index of national-income-method. The results proved that its economic benefit was marked.